Title
Development and Characterization of Nanoemulsion: Development and Characterization of Nanoemulsion containing selected model dru,Used
Sold by Ergodebooks, an authorized reseller.
Returns accepted within 30 days | support@ergodebooks.com
Shipping Information
- Free Standard Shipping — United States only
- Processing Time: 3–5 business days
- Estimated Delivery: 6–10 business days after dispatch
- Double-boxed, fully insured & discreetly packaged
- Tracking number sent via email once dispatched
Returns & Refund
Returns accepted within 30 days of delivery.
Damaged or Defective Item
Free return shipping + replacement or full refund
Wrong Item Received
Free return shipping + replacement or full refund
Change of Mind
Return shipping at customer's expense · 25% restocking fee applies
Payment Option
The knowledge base in Nanopharmaceuticals is growing rapidly, and with the increased understanding of complex biological systems it affords, coupled with increasingly reliable computational models for predicting outcomes, society is approaching healthcare that anticipates disease states rather than simply ameliorates disease symptoms. Innovative new technologies are changing the face of pharmaceutical R&D by allowing researchers to more effectively identify, select and exploit therapeutic targets, design more efficient drug development models and more quickly analyze the economic efficacy of pharmaceuticals. Nanotechnology comprises technological developments on the nanometer scale, usually 0.1 to 100 nm. Nanoemulsion Drug Delivery Systems (NEDDS) are isotropic mixtures of oil, surfactant and/or cosurfactants, and a drug that spontaneously forms an oilinwater nanoemulsion upon gentle agitation with water. The purpose of this research was to screen lipid excipients for their nanoemulsification efficiency and to develop nanoemulsion based formulation in liquid and solid forms using selected model drug.
⚠️ WARNING (California Proposition 65):
This product may contain chemicals known to the State of California to cause cancer, birth defects, or other reproductive harm.
For more information, please visit www.P65Warnings.ca.gov.